{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:49:44Z","timestamp":1772246984851,"version":"3.50.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>To provide a unique global view of the relative potential for evasion of CD8+ and CD4+ T cells by SARS-CoV-2 lineages as they evolve over time, we performed a comprehensive analysis of predicted HLA-I and HLA-II binding peptides in Spike (S) and Nucleocapsid (N) protein sequences of all available SARS-CoV-2 genomes as provided by NIH NCBI at a bi-monthly interval between March and December of 2021.\u00a0A data supplement of all B.1.1.529 (Omicron) genomes from GISAID in early December was also used to capture the rapidly spreading variant. A key finding is that throughout continued viral evolution and increasing rates of mutations occurring at T-cell epitope hotspots, protein instances with worst-case binding loss did not become the most frequent for any Variant of Concern (VOC) or Variant of Interest (VOI) lineage; suggesting T-cell evasion is not likely to be a dominant evolutionary pressure on SARS-CoV-2. We also determined that throughout the course of the pandemic in 2021, there remained a relatively steady ratio of viral variants that exhibit conservation of epitopes in the N protein, despite significant potential for epitope loss in S relative to other lineages. We further localized conserved regions in N with high epitope yield potential, and illustrated heterogeneity in HLA-I binding across the S protein consistent with empirical observations. Although Omicron\u2019s high volume of mutations caused it to exhibit more epitope loss potential than most frequently observed versions of proteins in almost all other VOCs, epitope candidates across its most frequent N proteins were still largely conserved. This analysis adds to the body of evidence suggesting that N may have merit as an additional antigen to elicit immune responses to vaccination with increased potential to provide sustained protection against COVID-19 disease in the face of emerging variants.<\/jats:p>","DOI":"10.3389\/fimmu.2022.918928","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:34:10Z","timestamp":1655962450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike"],"prefix":"10.3389","volume":"13","author":[{"given":"Kamil","family":"Wnuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremi","family":"Sudol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Spilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Soon-Shiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.02.010","article-title":"The Great Escape? SARS-CoV-2 Variants Evading Neutralizing Responses","volume":"293","author":"Pr\u00e9vost","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-9-1","article-title":"HLA Class I Supertypes: A Revised and Updated Classification","volume":"9","author":"Sidney","year":"2008","journal-title":"BMC Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"109164","DOI":"10.1016\/j.celrep.2021.109164","article-title":"Epitope Profiling Reveals Binding Signatures of SARS-CoV-2 Immune Response in Natural Infection and Cross-Reactivity With Endemic Human CoVs","volume":"358","author":"Stoddard","year":"2021","journal-title":"Cell Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations With Age and Disease Severity","volume":"183","author":"Moderbacher","year":"2020","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals With Asymptomatic or Mild COVID-19","volume":"1831","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early Induction of Functional SARS-CoV-2-Specific T Cells Associates With Rapid Viral Clearance and Mild Disease in COVID-19 Patients","volume":"346","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive Immunity to SARS-CoV-2 and COVID-19","volume":"1844","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00743-3","article-title":"SARS-CoV-2-Specific T Cells in Infection and Vaccination","volume":"1810","author":"Bertoletti","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 Human T Cell Epitopes: Adaptive Immune Response Against COVID-19","volume":"297","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009842","article-title":"Broadly Directed SARS-CoV-2-Specific CD4+ T Cell Response Includes Frequently Detected Peptide Specificities Within the Membrane and Nucleoprotein in Patients With Acute and Resolved COVID-19","volume":"179","author":"Heide","year":"2021","journal-title":"PloS Pathog"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T Cell Responses Targeting the SARS Coronavirus Persist Up to 11 Years Post-Infection","volume":"3417","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-Specific T Cell Immunity in Cases of COVID-19 and SARS, and Uninfected Controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans With COVID-19 Disease and Unexposed Individuals","volume":"1817","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.xcrm.2021.100204","article-title":"Comprehensive Analysis of T Cell Immunodominance and Immunoprevalence of SARS-CoV-2 Epitopes in COVID-19 Cases","volume":"22","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.19.344911","article-title":"SARS-CoV-2 Genome-Wide T Cell Epitope Mapping Reveals Immunodominance and Substantial CD8(+) T Cell Activation in COVID-19 Patients","volume":"658","author":"Saini","year":"2021","journal-title":"Sci Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100355","DOI":"10.1016\/j.xcrm.2021.100355","article-title":"Impact of SARS-CoV-2 Variants on the Total CD4+ and CD8+T-Cell Reactivity in Infected or Vaccinated Individuals","volume":"27","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04085-y","article-title":"Impact of Circulating SARS-CoV-2 Variants on mRNA Vaccine-Induced Immunity","volume":"600","author":"Lucas","year":"2021","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg6461","article-title":"SARS-CoV-2 Mutations in MHC-I-Restricted Epitopes Evade CD8(+) T Cell Responses","volume":"657","author":"Agerer","year":"2021","journal-title":"Sci Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"112816","DOI":"10.1016\/j.envres.2022.112816","article-title":"Emergence of SARS-CoV-2 Omicron (B.1.1.529) Variant, Salient Features, High Global Health Concerns and Strategies to Counter It Amid Ongoing COVID-19 Pandemic","volume":"209","author":"Khandia","year":"2022","journal-title":"Environ Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729837","article-title":"Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge","volume":"12","author":"Gabitzsch","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 Vaccines in Development","volume":"5867830","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2021.04.05.21254940","DOI":"10.1101\/2021.1104.1105.21254940","article-title":"Prime Had5 Spike Plus Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects That are Sustained Against Spike Variants","author":"Sieling","year":"2021","journal-title":"medRxiv"},{"key":"B23","article-title":"NIH National Library of Medicine","volume-title":"NCBI Reference Sequence Nc_045512.2","year":"2020"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor","volume":"5817807","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"B25","volume-title":"SARS-CoV-2 Variant Classifications and Definitions","year":"2021"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12984","article-title":"Development of a Novel Clustering Tool for Linear Peptide Sequences","volume":"1553","author":"Dhanda","year":"2018","journal-title":"Immunology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty463","article-title":"ImmunomeBrowser: A Tool to Aggregate and Visualize Complex and Heterogeneous Epitopes in Reference Proteins","volume":"3422","author":"Dhanda","year":"2018","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 Update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID's Role in Pandemic Response","volume":"349","author":"Khare","year":"2021","journal-title":"China CDC Wkly"},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, Disease and Diplomacy: GISAID's Innovative Contribution to Global Health","volume":"11","author":"Elbe","year":"2017","journal-title":"Global Challenges (Hoboken NJ)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: Global Initiative on Sharing All Influenza Data - From Vision to Reality","volume":"2213","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00510-20","article-title":"Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cels.2018.05.014","article-title":"MHCflurry: Open-Source Class I MHC Binding Affinity Prediction","volume":"71","author":"O'Donnell","year":"2018","journal-title":"Cell Syst"},{"key":"B34","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved Predictions of MHC Antigen Presentation by Concurrent Motif Deconvolution and Integration of MS MHC Eluted Ligand Data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data","volume":"1999","author":"Jurtz","year":"2017","journal-title":"J Immunol (Baltimore Md 1950"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88590","article-title":"MHC Class I-Associated Peptides Derive From Selective Regions of the Human Genome","volume":"12612","author":"Pearson","year":"2016","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1109\/CVPR.2019.00949","article-title":"Class-Balanced Loss Based on Effective Number of Samples","volume":"2019","author":"Cui","year":"2019","journal-title":"CVPR"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800914","article-title":"The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands","volume":"20112","author":"Gfeller","year":"2018","journal-title":"J Immunol (Baltimore Md 1950"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/098780","article-title":"Deciphering HLA-I Motifs Across HLA Peptidomes Improves Neo-Antigen Predictions and Identifies Allostery Regulating HLA Specificity","volume":"138","author":"Bassani-Sternberg","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"B40","article-title":"Simple and Scalable Predictive Uncertainty Estimation Using Deep Ensembles","volume-title":"31st Conference on Neural Information Processing Systems (NIPS)","author":"Lakshminarayanan","year":"2017"},{"key":"B41","article-title":"Nomenclature for Factors of the HL-A System","volume":"39","year":"1968","journal-title":"Bull World Health Organ"},{"key":"B42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01466.x","article-title":"Nomenclature for Factors of the HLA System, 2010","volume":"754","author":"Marsh","year":"2010","journal-title":"Tissue Antigens"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01716","article-title":"Predicting Antigen Presentation-What Could We Learn From a Million Peptides","volume":"9","author":"Gfeller","year":"2018","journal-title":"Front Immunol"},{"key":"B44","volume-title":"IPD-IMGT\/HLA Database","year":"2021"},{"key":"B45","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkz950","article-title":"IPD-IMGT\/HLA Database","volume":"48","author":"Robinson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0336-3","article-title":"Visualizing Structure and Transitions in High-Dimensional Biological Data","volume":"3712","author":"Moon","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"D783","DOI":"10.1093\/nar\/gkz1029","article-title":"Allele Frequency Net Database (AFND) 2020 Update: Gold-Standard Data Classification, Open Access Genotype Data and New Query Tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B48","volume-title":"Allele Frequency Net Database (AFND)","year":"2021"},{"key":"B49","doi-asserted-by":"publisher","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of Epidemiological Lineages in an Emerging Pandemic Using the Pangolin Tool","volume":"72","author":"O\u2019Toole","year":"2021","journal-title":"Virus Evol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0770-5","article-title":"A Dynamic Nomenclature Proposal for SARS-CoV-2 Lineages to Assist Genomic Epidemiology","volume":"511","author":"Rambaut","year":"2020","journal-title":"Nat Microbiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"i07","DOI":"10.18637\/jss.v031.i07","article-title":"Computing and Visualing Dynamic Time Warping Alignments in R: The Dtw Package","volume":"31","author":"Giorgino","year":"2009","journal-title":"J Stat Soft"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability","volume":"304","author":"Katoh","year":"2013","journal-title":"Mol Biol Evol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.918928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:34:39Z","timestamp":1655962479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.918928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2022.918928"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.918928","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.18.484954","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"918928"}}